Registered outcomes57

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 20 of 57

List	Outcome	Time frame	Description
Primary	FSH Level	Baseline (Before isotretinoin treatment)	Evaluation FSH levels in Severe Acne Vulgaris patient Before isotretinoin treatment
Primary	FSH Level	3rd month of isotretinoin treatment	Evaluation FSH levels in after 3 month of isotretinoin treatment
Primary	LH Level	Baseline (Before isotretinoin treatment)	Evaluation LH levels in Severe Acne Vulgaris patient Before isotretinoin treatment
Primary	LH Level	3rd month of isotretinoin treatment	Evaluation LH levels after 3 month of isotretinoin treatment
Primary	Prolactin Level	Baseline (Before isotretinoin treatment)	Evaluation Prolactin levels in Severe Acne Vulgaris patient Before isotretinoin treatment
Primary	Prolactin Level	3rd month of isotretinoin treatment	Evaluation Prolactin levels after 3 month of isotretinoin treatment
Primary	Estrogen Level	Baseline (Before isotretinoin treatment)	Evaluation Estrogen levels in Severe Acne Vulgaris patient Before isotretinoin treatment
Primary	Estrogen Level	3rd month of isotretinoin treatment	Evaluation Estrogen levels after 3 month of isotretinoin treatment
Primary	Testosterone Level	Baseline (Before isotretinoin treatment)	Evaluation Testosterone levels in Severe Acne Vulgaris patient Before isotretinoin treatment
Primary	Testosterone Level	3rd month of isotretinoin treatment	Evaluation Testosterone levels after 3 month of isotretinoin treatment
Primary	Free-Testosterone Level	Baseline (Before isotretinoin treatment)	Evaluation Free-Testosterone levels in Severe Acne Vulgaris patient Before isotretinoin treatment
Primary	Free-Testosterone Level	3rd month of isotretinoin treatment	Evaluation Free-Testosterone levels after 3 month of isotretinoin treatment
Primary	DHEA-s Level	Baseline (Before isotretinoin treatment)	Evaluation DHEA-s levels in Severe Acne Vulgaris patient Before isotretinoin treatment
Primary	DHEA-s Level	3rd month of isotretinoin treatment	Evaluation DHEA-s levels after 3 month of isotretinoin treatment
Primary	SHBG Level	Baseline (Before isotretinoin treatment)	Evaluation SHBG levels in Severe Acne Vulgaris patient Before isotretinoin treatment
Primary	SHBG Level	3rd month of isotretinoin treatment	Evaluation SHBG levels after 3 month of isotretinoin treatment
Primary	TSH Level	Baseline (Before isotretinoin treatment)	Evaluation TSH levels in Severe Acne Vulgaris patient Before isotretinoin treatment
Primary	TSH Level	3rd month of isotretinoin treatment	Evaluation TSH levels iafter 3 month of isotretinoin treatment
Primary	T4 Level	Baseline (Before isotretinoin treatment)	Evaluation T4 levels in Severe Acne Vulgaris patient Before isotretinoin treatment
Primary	T4 Level	3rd month of isotretinoin treatment	Evaluation T4 levels after 3 month of isotretinoin treatment

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05903716/registered

API reference For AI assistants

Registered outcomes57

Sources 3

Read this list from software.